陶氏病
进行性核上麻痹
神经科学
皮质基底变性
τ蛋白
微管
生物
疾病
神经退行性变
心理学
医学
病理
阿尔茨海默病
细胞生物学
作者
Thomas W. Rösler,Amir Tayaranian Marvian,Matthias Brendel,Niko-Petteri Nykänen,Matthias Höllerhage,Sigrid C. Schwarz,Franziska Hopfner,Thomas Koeglsperger,Gesine Respondek,Kerstin Schweyer,Chengjie Xiong,Victor L. Villemagne,Henryk Barthel,Osama Sabri,Ulrich Müller,Wassilios G. Meissner,Gábor G. Kovács,Günter U. Höglinger
标识
DOI:10.1016/j.pneurobio.2019.101644
摘要
Tau is a microtubule-associated protein with versatile functions in the dynamic assembly of the neuronal cytoskeleton. Four-repeat (4R-) tauopathies are a group of neurodegenerative diseases defined by cytoplasmic inclusions predominantly composed of tau protein isoforms with four microtubule-binding domains. Progressive supranuclear palsy, corticobasal degeneration, argyrophilic grain disease or glial globular tauopathy belong to the group of 4R-tauopathies. The present review provides an introduction in the current concept of 4R-tauopathies, including an overview of the neuropathological and clinical spectrum of these diseases. It describes the genetic and environmental etiological factors, as well as the contemporary knowledge about the pathophysiological mechanisms, including post-translational modifications, aggregation and fragmentation of tau, as well as the role of protein degradation mechanisms. Furthermore, current theories about disease propagation are discussed, involving different extracellular tau species and their cellular release and uptake mechanisms. Finally, molecular diagnostic tools for 4R-tauopathies, including tau-PET and fluid biomarkers, and investigational therapeutic strategies are presented. In summary, we report on 4R-tauopathies as overarching disease concept based on a shared pathophysiological concept, and highlight the challenges and opportunities on the way towards a causal therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI